Emergence of Novel Technologies to Aid Market Growth

Histology and cytology are the critical area of study in the medical field wherein diseases in organs, tissues, and bodily fluids are diagnosed. Histology and cytology are an integral part of pathology and due to research & development activities and advancements in technology, the adoption of histology and cytology is expected to scale new heights in the upcoming decade. Advancements in digital pathology are set to pave the way for innovations, data collection techniques, and diagnostic care over the course of the next few years due to which, the global histology & cytology market is staring at a bright future.

Technological advancements are expected to redefine the pathological field in the upcoming years wherein gathering, processing, and utilizing the data with utmost efficiency is projected to gain momentum– a factor that is anticipated to propel the global histology & cytology market during the assessment period. Progress in precision medicine is also expected to accelerate the growth of the market for histology and cytology during the forecast period, as more number of medical experts are increasingly moving away from the one-size-fits-all approach. The increasing correlation between data derived from various patient tests conducted and clinical data is anticipated to provide considerable boost to the overall growth of the global histology & cytology market in the upcoming years.

At the back of these factors, along with fast-paced integration of molecular diagnostic assays into pathology that continue to revolutionize the field of diagnostic cytology, the global histology & cytology market is on the course to attain a market value of US$ 28.7 Bn by the end of 2030. Increasing prevalence of cancer and growing awareness pertaining to the benefits of cervical cancer screening programs are likely to provide a further boost to the overall growth of the global histology & cytology market during the assessment period.

Request a sample to get extensive insights into the Histology & Cytology Market

Integration of Digital Technologies to Shape Future of Pathology

Pathology is one of the key elements of the global healthcare ecosystem and in the current day and age, traditional pathological techniques are gradually being replaced with advanced and modern pathological advancements. The onset of digital technologies is likely to shape the future of the global histology & cytology market in terms of boosting efficiency and scalability. Furthermore, the growing adoption of digital technologies is expected to accelerate the speed and accuracy of diagnosis due to which, the concept of digital pathology is gaining considerable traction worldwide.

The growing adoption of digital whole-slide-imaging (WSI) enables pathologists to visualize and capture the complete tissue on the slide in comparison with the view provided by the microscope– a factor that is expected to improve the accuracy of pathological processes and minimize its subjectivity. Digital slides pave the way for computer-assisted quantitative analytics, speedier image search, and efficient retrieval of slides. The global histology & cytology market is expected to take the digital path in the upcoming years, as digital technologies continue to bridge the gap between medical experts and patients. The growing adoption of artificial intelligence (AI) is projected to provide fertile grounds for the growth to the players operating in the current histology & cytology market. Advancements in precision medicine and AI are anticipated to improve care delivery due to which, more number of pathologists around the world are increasing embracing digital technologies. This factor is likely to provide a boost to the global histology & cytology market during the assessment period.

To understand how our report can bring difference to your business strategy, Ask for a brochure

COVID-19 Crisis: Adoption on Rise as Experts Focus on Gathering Data on Pathological Changes in Various Organs

The onset of the coronavirus disease (COVID-19) has inflicted a threat to public health worldwide. The outbreak of the COVID-19 pandemic is expected have a moderate impact on the global histology & cytology market in 2020. The healthcare sector, by and large, is expected to function in full swing during the pandemic, as governments have categorized healthcare services as essential. Furthermore, during the ongoing COVID-19 crisis, researchers and medical experts are increasingly focusing on understanding pathological changes in various organs in patients affected by COVID-19. Although COVID-19 primarily affects respiratory and the immune system, the disease could also have a compromising effect on other systems, including urinary and gastrointestinal tract, cardiovascular, reproductive system, integumentary system, and nervous system.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Histology & Cytology Market

Analysts’ Viewpoint

The global histology & cytology market is expected to expand at an impressive CAGR of ~10% during the forecast period. Increasing prevalence of cancer cases worldwide, advancements in pathological research, advent of digital technologies, along with growing support from governments are some of the key factors anticipated to drive the global histology & cytology market during the assessment period. Moreover, the integration of digital technologies such as AI will redefine the histology & cytology market landscape in the upcoming years, and boost efficiency and accuracy of pathological tests.

Histology & Cytology Market: Overview

  • A pathology laboratory consists of two areas: histopathology and cytopathology. Histology involves the study of tissues and cytology involves the study of cells. Tissues and cells are derived from various organs of the human body.
  • The histology laboratory is responsible for the preparation of tissue for diagnosis by pathologists. The cytology laboratory is capable of detecting microscopic cancerous and pre-cancerous changes that occur at the cellular level, often long before the clinical symptoms occur (e.g. the Pap smear).
  • Rise in prevalence of cancer and increase in automation in cytology and histology are projected to drive the global histology & cytology market. Increase in awareness about cancer diagnostics and incorporation of automation in cytology & histology are anticipated to augment the global market in the near future.
  • The global prevalence of cancer has been rising significantly, and the disease is considered the second major cause of death after cardiovascular diseases. Various factors contributing to the rise in prevalence of cancer include urbanization, tobacco smoking, increasing pollution, changing diet patterns, and surge in the post-reproductive life span.
  • According to the National Cancer Institute, over 1,806,590 new cases of cancer are anticipated to be diagnosed in the U.S. in 2020. The most common types of cancer affecting people include breast, prostate, lung & bronchus, bladder, non-Hodgkin’s lymphoma, pancreatic, thyroid, and liver.
  • Incorporation of automation aids in improving the accuracy of test results and shortening the time needed to perform the tests. Major types of automated devices employed in cytology laboratories include specimen collection and preparation devices, manual screening adjunctive devices, and automated screening devices. In 2019, Hologic’s ThinPrep Genesis processor for cytology slide and molecular test preparation received CE IVD mark in Europe. This system increases the automation capabilities by preparing the slides for cytology as well as aliquot samples for molecular testing, thereby reducing manual sample handling.

Reimbursement for Cancer Screening

  • Government and non-government agencies provide reimbursement for cancer screening tests performed. Medicaid programs in all the states and in the District of Columbia provide reimbursement coverage for breast, cervical, and colorectal cancer screening. However, Medicaid reimbursements differ substantially among the states and are usually below Medicare reimbursement levels. Increase in the reimbursement levels for screening tests could aid in expanding the supply of facilities providing services for Medicaid beneficiaries.
  • Cancer Services Program offers reimbursement for cervical cytology or the Pap smear test once every three years for women aged 40 years and above with an intact cervix and a prior negative test. Furthermore, reimbursement is offered for cervical screening carried out through Pap smear for women aged between 21 years and 29 years at a frequency of three years.

Market Segmentation: Histology & Cytology Market

  • In terms of type of examination, the global histology & cytology market has been bifurcated into histology and cytology. The cytology segment has been split into cervical cancer, breast cancer, oral cancer, and others.
  • Based on product, the global histology & cytology market has been categorized into instruments & analysis software system and consumables & reagents
  • In terms of test type, the global histology & cytology market has been classified into microscopy methods, flow cytometry, and molecular genetic methods. The microscopy methods segment has been segregated into cytochemistry & histochemistry and immunohistochemistry & immunofluorescence. The molecular genetic methods segment has been split into cytogenic tests, polymerase chain reaction, and others.
  • Based on end user, the global histology & cytology market has been divided into hospitals & clinics, academic & research institutes, and others
  • Each of the segments has been analyzed in detail for histology & cytology trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The histology & cytology market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030, along with market size estimations.

Regional Overview: Histology & Cytology Market

  • In terms of region, the global histology & cytology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • Stringent government regulations, presence of large-scale research units, and awareness about drug safety are the key factors projected to augment the market in North America. The market in Asia Pacific is driven by favorable business environment and government initiatives to improve healthcare infrastructure. Moreover, increase in focus on research & development is anticipated to augment the market in the region.
  • Current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the report for the period from 2018 to 2030, along with their CAGRs for the period from 2020 to 2030
  • The study also offers a list of recommendations, highlights, and useful insights of the market, which are estimated to help new companies willing to enter the market and existing companies to increase market share and in the decision-making process

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the global histology & cytology market
  • Leading players analyzed in the report are
    • Abbott
    • Becton
    • Dickinson and Company
    • Danaher
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Merck KGaA
    • PerkinElmer, Inc.
    • Sysmex Corporation
    • Thermo Fisher Scientific, Inc.
    • Trivitron Healthcare
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Histology & Cytology Market – Scope of the Report

TMR’s report on the global histology & cytology market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global histology & cytology market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global histology & cytology market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global histology & cytology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global histology & cytology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global histology & cytology market. These serve as valuable tools for existing market players as well as entities interested in participating in the global histology & cytology market.

The report also delves into the competition landscape of the global histology & cytology market. Key players operating in the global histology & cytology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global histology & cytology market that have been profiled in this report

Key Questions Answered in Histology & Cytology Report

  1. What is the sales/revenue generated by histology & cytology providers across all regions during the forecast period?
  2. What are the opportunities in the global histology & cytology market?
  3. What are the major drivers, restraints, opportunities, and threats in the global market?
  4. Which region is set to expand at the fastest CAGR during the forecast period?
  5. Which product segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  6. What are the market positions of different companies operating in the global market?

Histology & Cytology Market – Research Objectives and Research Approach

The comprehensive report on the global histology & cytology market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global histology & cytology market in terms of type of examination, test type, product, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global histology & cytology market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Histology & Cytology Market – Segmentation

TMR’s study on the global histology & cytology market includes information divided into five segments: type of examination, test type, product, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global histology & cytology market have been discussed in detail.

Type of Examination

  • Histology
  • Cytology

Product

  • Instruments & Analysis Software System
  • Consumables & Reagents

Test Type

  • Microscopy Methods
  • Flow Cytometry
  • Molecular Genetic Methods

End User

  • Hospitals & Clinics
  • Academic & Research Institutes
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Histology & Cytology Market

4. Market Overview

    4.1.  Introduction & Overview

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities

    4.3. Global Histology & Cytology Market Analysis and Forecast, 2018–2030

5. Market Outlook

    5.1. COVID-19 Pandemics Impact on Industry

    5.2. Regulatory Scenario by Region/globally

    5.3. Cancer Prevalence & Incidence Rate globally with key countries

    5.4. Technological Advancements

6. Global Histology & Cytology Market Analysis and Forecast, by Type of Examination

    6.1. Introduction & Definition    

    6.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

        6.2.1. Histology

        6.2.2. Cytology

            6.2.2.1. Cervical Cancer

            6.2.2.2. Breast Cancer

            6.2.2.3. Oral Cancer

            6.2.2.4. Others

    6.3. Global Histology & Cytology Market Attractiveness Analysis, by Type of Examination

7. Global Histology & Cytology Market Analysis and Forecast, by Product

    7.1. Introduction & Definition    

    7.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

        7.2.1. Instruments & Analysis Software System

        7.2.2. Consumables & Reagents

    7.3. Global Histology & Cytology Market Attractiveness Analysis, by Product

8. Global Histology & Cytology Market Analysis and Forecast, by Test Type

    8.1. Introduction & Definition    

    8.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        8.2.1. Microscopy methods

            8.2.1.1. Cytochemistry & Histochemistry

            8.2.1.2. Immunohistochemistry & Immunofluoroscence

        8.2.2. Flow Cytometry

        8.2.3. Molecular Genetic Methods

            8.2.3.1. Cytogenic Tests

            8.2.3.2. Polymerase Chain Reaction

            8.2.3.3. Others

    8.3. Global Histology & Cytology Market Attractiveness Analysis, by Test Type

9. Global Histology & Cytology Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition    

    9.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

        9.2.1. Hospitals & Clinics

        9.2.2. Academic & Research Institutes

        9.2.3. Others

    9.3. Global Histology & Cytology Market Attractiveness Analysis, by End-user

10. Global Histology & Cytology Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Global Histology & Cytology Market Attractiveness Analysis, by Region

11. North America Histology & Cytology Market Analysis and Forecast

    11.1. Introduction

    11.2. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

        11.2.1. Histology

        11.2.2. Cytology

            11.2.2.1. Cervical Cancer

            11.2.2.2. Breast Cancer

            11.2.2.3. Oral Cancer

            11.2.2.4. Others

    11.3. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

        11.3.1. Instruments & Analysis Software System

        11.3.2. Consumables & Reagents

    11.4. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        11.4.1. Microscopy Methods

            11.4.1.1. Cytochemistry & Histochemistry

            11.4.1.2. Immunohistochemistry & Immunofluoroscence

        11.4.2. Flow Cytometry

        11.4.3. Molecular Genetic Methods

            11.4.3.1. Cytogenic Tests

            11.4.3.2. Polymerase Chain Reaction

            11.4.3.3. Others

    11.5. North America Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

        11.5.1. Hospitals & Clinics

        11.5.2. Academic & Research Institutes

        11.5.3. Others

    11.6. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Country, 2018–2030

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Histology & Cytology Market Attractiveness Analysis

        11.7.1. By Type of Examination

        11.7.2. By Product

        11.7.3. By Test Type

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Histology & Cytology Market Analysis and Forecast

    12.1. Introduction

    12.2. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

        12.2.1. Histology

        12.2.2. Cytology

            12.2.2.1. Cervical Cancer

            12.2.2.2. Breast Cancer

            12.2.2.3. Oral Cancer

            12.2.2.4. Others

    12.3. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

        12.3.1. Instruments & Analysis Software System

        12.3.2. Consumables & Reagents

    12.4. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        12.4.1. Microscopy methods

            12.4.1.1. Cytochemistry & Histochemistry

            12.4.1.2. Immunohistochemistry & Immunofluoroscence

        12.4.2. Flow Cytometry

        12.4.3. Molecular Genetic Methods

            12.4.3.1. Cytogenic Tests

            12.4.3.2. Polymerase Chain Reaction

            12.4.3.3. Others

    12.5. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

        12.5.1. Hospitals & Clinics

        12.5.2. Academic & Research Institutes

        12.5.3. Others

    12.6. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Europe Histology & Cytology Market Attractiveness Analysis

        12.7.1. By Type of Examination

        12.7.2. By Product

        12.7.3. By Test Type

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Histology & Cytology Market Analysis and Forecast

    13.1. Introduction

    13.2. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

        13.2.1. Histology

        13.2.2. Cytology

            13.2.2.1. Cervical Cancer

            13.2.2.2. Breast Cancer

            13.2.2.3. Oral Cancer

            13.2.2.4. Others

    13.3. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

        13.3.1. Instruments & Analysis Software System

        13.3.2. Consumables & Reagents

    13.4. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        13.4.1. Microscopy Methods

            13.4.1.1. Cytochemistry & Histochemistry

            13.4.1.2. Immunohistochemistry & Immunofluoroscence

        13.4.2. Flow Cytometry

        13.4.3. Molecular Genetic Methods

            13.4.3.1. Cytogenic Tests

            13.4.3.2. Polymerase Chain Reaction

            13.4.3.3. Others

    13.5. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

        13.5.1. Hospitals & Clinics

        13.5.2. Academic & Research Institutes

        13.5.3. Others

    13.6. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Histology & Cytology Market Attractiveness Analysis

        13.7.1. By Type of Examination

        13.7.2. By Product

        13.7.3. By Test Type

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Histology & Cytology Market Analysis and Forecast

    14.1. Introduction

    14.2. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

        14.2.1. Histology

        14.2.2. Cytology

            14.2.2.1. Cervical Cancer

            14.2.2.2. Breast Cancer

            14.2.2.3. Oral Cancer

            14.2.2.4. Others

    14.3. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

        14.3.1. Instruments & Analysis Software System

        14.3.2. Consumables & Reagents

    14.4. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        14.4.1. Microscopy Methods

            14.4.1.1. Cytochemistry & Histochemistry

            14.4.1.2. Immunohistochemistry & Immunofluoroscence

        14.4.2. Flow Cytometry

        14.4.3. Molecular Genetic Methods

            14.4.3.1. Cytogenic Tests

            14.4.3.2. Polymerase Chain Reaction

            14.4.3.3. Others

    14.5. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

        14.5.1. Hospitals & Clinics

        14.5.2. Academic & Research Institutes

        14.5.3. Others

    14.6. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Histology & Cytology Market Attractiveness Analysis

        14.7.1. By Type of Examination

        14.7.2. By Product

        14.7.3. By Test Type

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

    14.8. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

        14.8.1. Instruments & Analysis Software System

        14.8.2. Consumables & Reagents

    14.9. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

        14.9.1. Microscopy Methods

            14.9.1.1. Cytochemistry & Histochemistry

            14.9.1.2. Immunohistochemistry & Immunofluoroscence

        14.9.2. Flow Cytometry

        14.9.3. Molecular Genetic Methods

            14.9.3.1. Cytogenic Tests

            14.9.3.2. Polymerase Chain Reaction

            14.9.3.3. Others

    14.10. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

        14.10.1. Hospitals & Clinics

        14.10.2. Academic & Research Institutes

        14.10.3. Others

    14.11. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

        14.11.1. GCC Countries

        14.11.2. South Africa

        14.11.3. Rest of Middle East & Africa

    14.12. Middle East & Africa Histology & Cytology Market Attractiveness Analysis

        14.12.1. By Type of Examination

        14.12.2. By Product

        14.12.3. By Test Type

        14.12.4. By End-user

        14.12.5. By Country/Sub-region

15. Competition Landscape

    15.1. Market Position Analysis, by Company, 2019

    15.2. Company Profiles

        15.2.1. Abbott

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Growth Strategies

            15.2.1.3. SWOT Analysis

        15.2.2. Becton Dickinson and Company

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Growth Strategies

            15.2.2.3. SWOT Analysis

        15.2.3. Danaher

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Growth Strategies

            15.2.3.3. SWOT Analysis

        15.2.4. F. Hoffmann-La Roche Ltd.

            15.2.4.1. Company Overview (HQ, Business Segments)

            15.2.4.2. Growth Strategies

            15.2.4.3. SWOT Analysis

        15.2.5. Hologic, Inc.

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Growth Strategies

            15.2.5.3. SWOT Analysis

        15.2.6. Merck KGaA

            15.2.6.1. Company Overview (HQ, Business Segments)

            15.2.6.2. Growth Strategies

            15.2.6.3. SWOT Analysis

        15.2.7. PerkinElmer Inc.

            15.2.7.1. Company Overview (HQ, Business Segments)

            15.2.7.2. Growth Strategies

            15.2.7.3. SWOT Analysis

        15.2.8. Sysmex Corporation

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Growth Strategies

            15.2.8.3. SWOT Analysis

        15.2.9. Thermo Fisher Scientific Inc.

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Growth Strategies

            15.2.9.3. SWOT Analysis

        15.2.10. Trivitron Healthcare

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Company Financials

            15.2.10.3. Growth Strategies

            15.2.10.4. SWOT Analysis

List of Tables

Table 01: Global Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

Table 02: Global Histology & Cytology Market Value (US$ Mn) Forecast, by Cytology, 2018–2030

Table 03: Global Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 04: Global Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

Table 05: Global Histology & Cytology Market Value (US$ Mn) Forecast, by Microscopy Methods, 2018–2030

Table 06: Global Histology & Cytology Market Value (US$ Mn) Forecast, by Molecular Genetic Methods, 2018–2030

Table 07: Global Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 08: Global Histology & Cytology Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: North America Histology & Cytology Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 10: North America Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

Table 11: North America Histology & Cytology Market Value (US$ Mn) Forecast, by Cytology, 2018–2030

Table 12: North America Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 13: North America Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

Table 14: North America Histology & Cytology Market Value (US$ Mn) Forecast, by Microscopy methods, 2018–2030

Table 15: North America Histology & Cytology Market Value (US$ Mn) Forecast, by Molecular Genetic Methods, 2018–2030

Table 16: North America Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 17: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

Table 19: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Cytology, 2018–2030

Table 20: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 21: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

Table 22: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Microscopy methods, 2018–2030

Table 23: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Molecular Genetic Methods, 2018–2030

Table 24: Europe Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 25: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

Table 27: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Cytology, 2018–2030

Table 28: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 29: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

Table 30: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Microscopy methods, 2018–2030

Table 31: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Molecular Genetic Methods, 2018–2030

Table 32: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 33: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 34: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

Table 35: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Cytology, 2018–2030

Table 36: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 37: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

Table 38: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Microscopy methods, 2018–2030

Table 39: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Molecular Genetic Methods, 2018–2030

Table 40: Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 41: Middle East & Africa Remote Patient Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 42: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2030

Table 43: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Cytology, 2018–2030

Table 44: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 45: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2030

Table 46: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Microscopy methods, 2018–2030

Table 47: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Molecular Genetic Methods, 2018–2030

Table 48: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01: Global Histology & Cytology Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Histology & Cytology Market Value Share, by Type of Examination, 2019

Figure 03: Global Histology & Cytology Market Value Share, by Product, 2019

Figure 04: Global Histology & Cytology Market Value Share, by Test Type, 2019

Figure 05: Global Histology & Cytology Market Value Share, by End-user, 2019

Figure 06: Global Histology & Cytology Market Value Share Analysis, by Type of Examination, 2019 and 2030

Figure 07: Global Histology & Cytology Market Attractiveness Analysis, by Type of Examination, 2020–2030

Figure 08: Global Histology & Cytology Market Value (US$ Mn), by Histology, 2018–2030

Figure 09: Global Histology & Cytology Market Value (US$ Mn), by Cytology, 2018–2030

Figure 10: Global Histology & Cytology Market Value Share Analysis, by Product, 2019 and 2030

Figure 11: Global Histology & Cytology Market Attractiveness Analysis, by Product, 2020–2030

Figure 12: Global Histology & Cytology Market Value (US$ Mn), by Instruments and Analysis Software System, 2018–2030

Figure 13: Global Histology & Cytology Market Value (US$ Mn), by Consumables and Reagents, 2018–2030

Figure 14: Global Histology & Cytology Market Value Share Analysis, by Test Type, 2019 and 2030

Figure 15: Global Histology & Cytology Market Attractiveness Analysis, by Test Type, 2020–2030

Figure 16: Global Histology & Cytology Market Value (US$ Mn), by Microscopy Methods, 2018–2030

Figure 17: Global Histology & Cytology Market Value (US$ Mn), by Flow Cytometry, 2018–2030

Figure 18: Global Histology & Cytology Market Value (US$ Mn), by Molecular Genetic Methods, 2018–2030

Figure 19: Global Histology & Cytology Market Value Share Analysis, by Test Type, 2019 and 2030

Figure 20: Global Histology & Cytology Market Attractiveness Analysis, by Test Type, 2020–2030

Figure 21: Global Histology & Cytology Market Value (US$ Mn), by Hospitals & Clinics, 2018–2030

Figure 22: Global Histology & Cytology Market Value (US$ Mn), by Academic & Research Institutes, 2018–2030

Figure 23: Global Histology & Cytology Market Value (US$ Mn), by Others, 2018–2030

Figure 24: Global Histology & Cytology Market Value Share Analysis, by Region, 2019 and 2030

Figure 25: Global Histology & Cytology Market Attractiveness Analysis, by Region, 2020–2030

Figure 26: North America Histology & Cytology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 27: North America Histology & Cytology Market Value Share (%), by Country, 2019 and 2030

Figure 28: North America Histology & Cytology Market Attractiveness Analysis, by Country, 2020–2030

Figure 29: North America Histology & Cytology Market Value Share (%), by Type of Examination, 2019 and 2030

Figure 30: North America Histology & Cytology Market Attractiveness Analysis, by Type of Examination, 2020–2030

Figure 31: North America Histology & Cytology Market Value Share (%), by Product, 2019 and 2030

Figure 32: North America Histology & Cytology Market Attractiveness Analysis, by Product, 2020–2030

Figure 33: North America Histology & Cytology Market Value Share (%), by Test Type, 2019 and 2030

Figure 34: North America Histology & Cytology Market Attractiveness Analysis, by Test Type, 2020–2030

Figure 35: North America Histology & Cytology Market Value Share (%), by End-user, 2019 and 2030

Figure 36: North America Histology & Cytology Market Attractiveness Analysis, by End-user, 2020–2030

Figure 37: Europe Histology & Cytology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 38: Europe Histology & Cytology Market Value Share, by Country/Sub-region, 2019–2030

Figure 39: Europe Histology & Cytology Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 40: Europe Histology & Cytology Market Value Share (%), by Type of Examination, 2019 and 2030

Figure 41: Europe Histology & Cytology Market Attractiveness Analysis, by Type of Examination, 2020–2030

Figure 42: Europe Histology & Cytology Market Value Share (%), by Product, 2019 and 2030

Figure 43: Europe Histology & Cytology Market Attractiveness Analysis, by Product, 2020–2030

Figure 44: Europe Histology & Cytology Market Value Share (%), by Test Type, 2019 and 2030

Figure 45: Europe Histology & Cytology Market Attractiveness Analysis, by Test Type, 2020–2030

Figure 46: Europe Histology & Cytology Market Value Share (%), by End-user, 2019 and 2030

Figure 47: Europe Histology & Cytology Market Attractiveness Analysis, by End-user, 2020–2030

Figure 48: Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 49: Asia Pacific Histology & Cytology Market Value Share (%), by Country/Sub-region, 2019 and 2030

Figure 50: Asia Pacific Histology & Cytology Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 51: Asia Pacific Histology & Cytology Market Value Share (%), by Type of Examination, 2019 and 2030

Figure 52: Asia Pacific Histology & Cytology Market Attractiveness Analysis, by Type of Examination, 2020–2030

Figure 53: Asia Pacific Histology & Cytology Market Value Share (%), by Product, 2019 and 2030

Figure 54: Asia Pacific Histology & Cytology Market Attractiveness Analysis, by Product, 2020–2030

Figure 55: Asia Pacific Histology & Cytology Market Value Share (%), by Test Type, 2019 and 2030

Figure 56: Asia Pacific Histology & Cytology Market Attractiveness Analysis, by Test Type, 2020–2030

Figure 57: Asia Pacific Histology & Cytology Market Value Share (%), by End-user, 2019 and 2030

Figure 58: Asia Pacific Histology & Cytology Market Attractiveness Analysis, by End-user, 2020–2030

Figure 59: Latin America Histology & Cytology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 60: Latin America Histology & Cytology Market Value Share, by Country/Sub-region, 2019–2030

Figure 61: Latin America Histology & Cytology Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 62: Latin America Histology & Cytology Market Value Share (%), by Type of Examination, 2019 and 2030

Figure 63: Latin America Histology & Cytology Market Attractiveness Analysis, by Type of Examination, 2020–2030

Figure 64: Latin America Histology & Cytology Market Value Share (%), by Product, 2019 and 2030

Figure 65: Latin America Histology & Cytology Market Attractiveness Analysis, by Product, 2020–2030

Figure 66: Latin America Histology & Cytology Market Value Share (%), by Test Type, 2019 and 2030

Figure 67: Latin America Histology & Cytology Market Attractiveness Analysis, by Test Type, 2020–2030

Figure 68: Latin America Histology & Cytology Market Value Share (%), by End-user, 2019 and 2030

Figure 69: Latin America Histology & Cytology Market Attractiveness Analysis, by End-user, 2020–2030

Figure 70: Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 71: Middle East & Africa Remote Patient Monitoring Devices Market Value Share, by Country/Sub-region, 2019–2030

Figure 72: Middle East & Africa Remote Patient Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 73: Middle East & Africa Histology & Cytology Market Value Share (%), by Type of Examination, 2019 and 2030

Figure 74: Middle East & Africa Histology & Cytology Market Attractiveness Analysis, by Type of Examination, 2020–2030

Figure 75: Middle East & Africa Histology & Cytology Market Value Share (%), by Product, 2019 and 2030

Figure 76: Middle East & Africa Histology & Cytology Market Attractiveness Analysis, by Product, 2020–2030

Figure 77: Middle East & Africa Histology & Cytology Market Value Share (%), by Test Type, 2019 and 2030

Figure 78: Middle East & Africa Histology & Cytology Market Attractiveness Analysis, by Test Type, 2020–2030

Figure 79: Middle East & Africa Histology & Cytology Market Value Share (%), by End-user, 2019 and 2030

Figure 80: Middle East & Africa Histology & Cytology Market Attractiveness Analysis, by End-user, 2020–2030

Figure 81: Global Histology & Cytology Market Share Analysis, by Company, 2019

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Histology Cytology Market